Tinea capitis dermatophytes: Susceptibility to antifungal drugs tested in vitro and in vivo

Dermatology

Volumn 197, Issue 4, 1998, Pages 361-367

  Mock, M ^a   Monod, M ^a   Baudraz Rosselet, F ^a,b   Panizzon, R G ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Laboratoire de Mycologie BT422   (Switzerland)

Author keywords

Dermatophytes; Itraconazole; Microsporum; Terbinafine; Tinea capitis; Trichophyton

Indexed keywords

GRISEOFULVIN; ITRACONAZOLE; TERBINAFINE;

ADULT; ALOPECIA; ANIMAL EXPERIMENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; MICROSPORUM CANIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TINEA CAPITIS; TRICHOPHYTON VIOLACEUM;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; CHILD; CHILD, PRESCHOOL; DERMATOMYCOSES; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MICROSPORUM; NAPHTHALENES; RETROSPECTIVE STUDIES; SWITZERLAND; TINEA CAPITIS; TRICHOPHYTON;

EID: 0032435207     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018032     Document Type: Article

References (30)

1. Abdel-Rahman SM, Nahata MC: Treatment of tinea capitis. Ann Pharmacother 1997;31: 338-348.
2. Lukacs A, Korting HC, Lindner A: Successful treatment of griseofulvin-resistant tinea capitis in infants: Case reports. Mycoses 1994;37: 451-453.
3. Artis WM, Odle BM, Jones HE: Gnseofulvin-resistant dermatophytosis correlates with in vitro resistance. Arch Dermatol 1981;117: 16-19.
4. Allen HB, Honig PJ, Leyden JJ, McGinley KJ: Selenium sulfide: Adjunctive therapy for tinea capitis. Pediatrics 1982;69:81-83.
5. Lopez-Gomez S, Del Palacio A, Van Cutsem J, Cuetara MS, Iglesias L, Rodriguez-Noriega A: Itraconazole versus griseofulvin in the treatment of tinea capitis: A double-blind randomized study in children. Int J Dermatol 1994; 33:743-747.
6. Legendre R, Esola-Macre J: Itraconazole in the treatment of tinea capitis. J Am Acad Dermatol 1990;23:559-560.
7. Greer DL: Treatment of tinea capitis with itraconazole. J Am Acad Dermatol 1996;35: 637-638.
8. Gupta AK, Alexis ME, Raboobee N, Hofstader SLR, Lynde CW, Adam P, Summerbell RC, De Doncker P: Itraconazole pulse therapy is effective in the treatment of tinea capitis in children: An open multicentre study. Br J Dermatol 1997;137:251-254.
9. Villars V, Jones TC: Clinical efficacy and tolerability of terbinafine (Lamisil®) - A new topical and systemic fungicidal drug for treatment of dermatomycoses. Clin Exp Dermatol 1989; 14:124-127.
10. Haroon TS, Hussain I, Mahmood A, Nagi AH, Ahmad I, Zahid M: An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis. Br J Dermatol 1992;26(suppl 39):47-50.
11. Nejjam F, Zagula M, Cabiac MD, Guessous N, Humbert H, Lakhdar H: Pilot study of terbinafine in children suffering from tinea capitis: Evaluation of efficacy, safety and pharmacokinetics. Br J Dermatol 1995;132: 98-105.
12. Jones TC: Overview of the use of terbinafine (Lamisil®) in children. Br J Dermatol 1995; 132:683-689.
13. Gruseck E, Splanemenn V, Bleck O, Ring J, Abeck D: Oral terbinafine in tinea capitis in children. Mycoses 1996;39:237-240.
14. Haroon TS, Hussain I, Aman S, Jahangir M, Kazmi AH, Sami AR, Nagi AH, Alvi KH, Iqbal N, Khan KA, Aziz R: A randomized double-blind comparative study of terbinafine for 1,2 and 4 weeks in tinea capitis. Br J Dermatol 1996;135:86-88.
15. Butty P, Lebecq J-C, Maillé M, Bastide J-M: Evaluation of the susceptibility testing of dermatophytes to antifungal drugs: A new technique. J Med Vet Mycol 1995;33:403-409.
16. Goh C-L, Tay YK: In vitro evaluation of griseofulvin, ketoconazole and itraconazole against various dermatophytes in Singapore. Int J Dermatol 1994;33:733-737.
17. Clayton YM: In vitro activity of terbinafine. Clin Exp Dermatol 1989;14:101-103.
18. Clayton YM: Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses. Br J Dermatol 1994;130(suppl 43):7-8.
19. Goudard M, Buffard Y, Ferrari H, Regli P: Spectre d'action in vitro d'un nouvel anti-fongique dérivé de la naftifine: la terbinafine (SF 86-327). Pathol Biol 1986;34:680-683.
20. Pankajalakshmi V, Taralakshmi V: Disk diffusion susceptibility testing of dermatophytes with allylamines. Int J Dermatol 1994;33: 730-732.
21. Van Cutsem J, Van Gerven F, Janssen PAJ: The in vitro evaluation of azoles; in Iwata K, Vanden Boosshe H (eds): In vitro and in vivo Evaluation of Antifungal Agents. Amsterdam, Elsevier Science Publishers (Biomedical Division), 1986, p 51.
22. Strobos MA, Oranje AP: Failure of terbinafine treatment in 2 children with tinea capitis (Dutch). Ned Tijdschr Geneeskd 1996;140: 1611-1612.
23. Dragos V, Lunder M: Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children. Pediatr Dermatol 1997;14:46-48.
24. Baudraz-Rosselet F, Monod M, Jaccoud S, Frenk E: Efficacy of terbinafine treatment of tinea capitis in children varies according to the dermatophytes species. Br J Dermatol 1996; 135:1011.
25. Faergemann J, Zehender H, Millerioux L: Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 days and 14 days. Clin Exp Dermatol 1994;19:121-126.
26. Finlay AY: Global overview of Lamisil®. Br J Dermatol 1994;130(suppl 43):1-3.
27. Baudraz-Rosselet F, Rakosi T, Willi PB, Kenzelmann R: Treatment of onychomycosis with terbinafine. Br J Dermatol 1992;126(suppl 39):40-46.
28. Ellis DH, Marley JE, Watson AB, Williams TG: Significance of non-dermatophyte moulds and yeast in onychomycosis. Dermatology 1997;194(suppl 1):40-42.
29. Abdel-Rahman SM, Nahata MC: Oral terbinafine: A new antifungal agent. Ann Pharmacother 1997;31:445-456.
30. Grigoriu D, Delacrétaz J, Borelli D: Traité de mycologie médicale. Lausanne, Payot, 1984.